ACM
SPPI

AlphaCrest Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

AlphaCrest Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,300
Closed -$168K – 1422
2019
Q3 		$168K Sell
20,300
-49,700
-71% -$402K 0.01% 1225
2019
Q2 		$603K Buy
+70,000
New +$626K 0.05% 626

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaCrest Capital Management's SPPI Position: Q4 2019 in Review

AlphaCrest Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2019, closing a stake of 20,300 shares — an estimated $168K sold.

AlphaCrest Capital Management first reported a position in SPPI in Q2 2019 and held it in 2 quarters. The position peaked at $603K in Q2 2019. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

  • AlphaCrest Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • AlphaCrest Capital Management sold 20,300 Spectrum Pharmaceuticals Inc shares in Q4 2019, an estimated $168K.
  • AlphaCrest Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and held it in 2 quarters.
  • AlphaCrest Capital Management's Spectrum Pharmaceuticals Inc position peaked at $603K in Q2 2019.
  • 169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on AlphaCrest Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.